$NMRA up 49% and cruising 👀 🔹 Momentum continues to build as biotech traders pile into the name 📈 🔹 Neumora is developing novel treatments for major depress

$NMRA up 49% and cruising 👀 🔹 Momentum continues to build as biotech traders pile into the name 📈 🔹 Neumora is developing novel treatments for major depressive disorder and other brain-related conditions 🧠 🔹 Lead program navacaprant remains one of the most closely watched assets in neuropsychi…